简介：目的：研究针刺对中风偏瘫痉挛状态的影响。方法：采用修改的Ashworth痉挛评定级、Brunnstrom分级、Barthel日常生活能力（ActivitiesofDailyLiving，ADL）指数分别评定痉挛程度、运动功能水平、日常生活能力，观察头针、体针联合应用对中风后偏瘫患者痉挛状态的影响。结果：头针、体针联合应用对痉挛状态的改善，对运动功能水平及日常生活能力的影响均优于单纯体针治疗（P〈0．01）。结论：头针、体针联合应用在改善痉挛状态方面有独特的优势，可提高患者的运动功能水平及日常生活能力。

简介：AbstractHereditary spastic paraplegia type 56 (SPG56-HSP) is a rare autosomal recessive disorder caused by loss of function mutations in CYP2U1, leading to an early-onset limbs spasticity, often complicated by additional neurological or extra-neurological manifestations. Given its low prevalence, the molecular bases underlying SPG56-HSP are still poorly understood, and effective treatment options are still lacking. Recently, through the generation and characterization of the SPG56-HSP mouse model, we were able to take few important steps forward in expanding our knowledge of the molecular background underlying this complex disease. Leveraging the Cyp2u1-/- mouse model we were able to identify several new diagnostics biomarkers (vitamin B2, coenzyme Q, neopterin, and interferon-alpha), as well as to highlight the key role played by the folate pathway in SPG56-HSP pathogenesis, providing a potential treatment option. In this review, we discuss the major role played by the Cyp2u1-/- model in dissecting clinical and biological aspects of the disease, opening the way to a series of new research paths ranging from clinical trials, biomarker testing, and to the expansion of the underlying genetic and molecular, emphasizing how basic mouse model characterization could contribute to advance research in the context of rare disorders.

简介：摘要PurposeTo evaluate the efficacy and safety of radial extracorporeal shock wave therapy (rESWT) according to total number of pulses on hamstring muscle spasticity in children with spastic type cerebral palsy (CP)．MethodsThis study is a randomized controlled trial consisting of thirteen patients with spastic CP, 9 males and 4 females, aged 5 to 14 years (mean age 9.2). Twenty-five spastic hamstring muscles were divided in four groups. Group I: 500 pulses, Group II: 1，000 pulses, Group III: 1，500 pulses, and Group IV: 2，000 pulses. Australian Spasticity Assessment Scale (ASAS) was measured at four different time points (pre-ESWT, post-ESWT, 2 weeks post-ESWT, and 4 weeks post-ESWT)．ResultsAll four groups showed improvement in ASAS relative to pre-treatment, although only significant in Group III (1，500 pulses). There were no statistically significant differences in ASAS between all four groups in pre-ESWT [|2(2)＝3.907, P＝0.272], immediately post-ESWT [|2(2)＝1.250, P＝0.741], 2 weeks post-ESWT vs pre-ESWT [|2(2)＝3.367, P＝0.338], and 4 weeks post-ESWT vs pre-ESWT [|2(2)＝1.566, P＝0.667]．ConclusionThe effect of rESWT on spastic hamstring in children with spastic CP is not dependent on the number of pulses.